[Human plasma paraoxonase (HuPON1): an anti-atherogenic enzyme with organophosphate hydrolase activity].
Human plasma paraoxonase (PON1) is a calcium-dependent organophosphate-hydrolase. In plasma, PON1 is bound to high-density lipoproteins (HDL). PON1 prevents the oxidation of LDL and scavenges oxidized phospholipids, thus protecting from atherogenesis. Improving the prophylaxis and treatment of organophosphate (OP) poisoning is a public health concern that also interests the civilian safety and the military. In this context, engineering and formulation of enzymes able to scavenge or hydrolyze OPs, such as PON1, are widely studied. Determination of the PON1 three-dimensional structure is a key step toward improvement of the enzyme functional properties.
Josse
D
D
Centre de Recherches du Service de Santé des Armées, 24 avenue des Maquis du Grésivaudan, BP87, F38702 La Tronche cedex, France.
Masson
P
P
D001161:Arteriosclerosis / Q000517:prevention & control*; D043303:Aryldialkylphosphatase; D004950:Esterases / Q000097:blood* / Q000737:chemistry / Q000235:genetics; D006801:Humans; D008075:Lipoproteins, HDL / Q000097:blood*; D062025:Organophosphate Poisoning; D010755:Organophosphates / Q000493:pharmacokinetics*; D010084:Oxidation-Reduction; D010743:Phospholipids / Q000097:blood; D013379:Substrate Specificity
D008075:Lipoproteins, HDL; D010755:Organophosphates; D010743:Phospholipids; D004950:Esterases; D043303:Aryldialkylphosphatase; C468406:PON1 protein, human